New drug BL0175 tested for advanced Hormone-Positive cancers
Disease control
Recruiting now
This early-phase study tests an investigational drug called BL0175 in postmenopausal women with advanced breast, ovarian, or endometrial cancer that is hormone receptor-positive. The main goals are to check the drug's safety, find the best dose, and see if it helps shrink or cont…
Phase: PHASE1 • Sponsor: Shanghai Best-Link Bioscience, LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC